Zhaoke Ophthalmology Limited (HKG:6622)
2.910
-0.020 (-0.68%)
At close: Mar 27, 2026
Zhaoke Ophthalmology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 959.31 | 1,121 | 1,462 | 1,716 | 2,128 |
Short-Term Investments | 1.5 | 70.16 | - | 8.87 | 8.16 |
Cash & Short-Term Investments | 960.81 | 1,191 | 1,462 | 1,725 | 2,137 |
Cash Growth | -19.34% | -18.50% | -15.28% | -19.25% | 145.21% |
Accounts Receivable | 14.1 | 0.38 | 3.71 | - | - |
Other Receivables | 30.68 | 11.32 | 18.83 | 48.07 | 14.57 |
Receivables | 44.78 | 11.7 | 22.54 | 48.07 | 14.57 |
Inventory | 14.63 | 14.9 | 6.14 | - | - |
Restricted Cash | 336.43 | 356.3 | 265.66 | 172.07 | 25.51 |
Other Current Assets | 17.2 | 40.86 | 38.61 | 27.38 | 32.23 |
Total Current Assets | 1,374 | 1,615 | 1,795 | 1,973 | 2,209 |
Property, Plant & Equipment | 158.61 | 192.14 | 223.65 | 233.74 | 184.32 |
Other Intangible Assets | 383.64 | 413.55 | 392.46 | 334.62 | 162.38 |
Other Long-Term Assets | 19.22 | 22.91 | 9.66 | 29.51 | 49.81 |
Total Assets | 1,935 | 2,244 | 2,420 | 2,571 | 2,605 |
Accounts Payable | 1.93 | 2.78 | 9.27 | 11.05 | 14.69 |
Accrued Expenses | 37.59 | 80.67 | 101.47 | 61.81 | 24.23 |
Short-Term Debt | 270.37 | 212.61 | 206.58 | 94.5 | 10.29 |
Current Portion of Leases | 12.58 | 9.93 | 9.59 | 9.73 | 5.88 |
Current Income Taxes Payable | 0.75 | - | - | - | 5.53 |
Current Unearned Revenue | 1.73 | 1.37 | 1.18 | - | - |
Other Current Liabilities | 3.47 | 5.69 | 8.38 | 17.46 | 28.39 |
Total Current Liabilities | 328.41 | 313.05 | 336.45 | 194.54 | 89.01 |
Long-Term Leases | 9.4 | 16.05 | 21.86 | 27.7 | 20.86 |
Long-Term Unearned Revenue | 21.49 | 14.21 | 13.71 | 0.01 | 0.05 |
Pension & Post-Retirement Benefits | 0.12 | 0.13 | - | - | - |
Total Liabilities | 359.43 | 343.44 | 372.02 | 222.25 | 109.92 |
Additional Paid-In Capital | - | 5,444 | 5,444 | 5,428 | 5,414 |
Retained Earnings | - | -4,035 | -3,807 | -3,429 | -3,022 |
Comprehensive Income & Other | 1,576 | 491.19 | 411.54 | 350.14 | 103.48 |
Shareholders' Equity | 1,576 | 1,900 | 2,048 | 2,348 | 2,495 |
Total Liabilities & Equity | 1,935 | 2,244 | 2,420 | 2,571 | 2,605 |
Total Debt | 292.36 | 238.59 | 238.03 | 131.93 | 37.03 |
Net Cash (Debt) | 668.46 | 952.57 | 1,224 | 1,593 | 2,100 |
Net Cash Growth | -29.83% | -22.15% | -23.20% | -24.11% | - |
Net Cash Per Share | 1.22 | 1.74 | 2.25 | 2.94 | 5.09 |
Filing Date Shares Outstanding | 547.73 | 546.14 | 546.14 | 543.84 | 541.95 |
Total Common Shares Outstanding | 547.73 | 546.14 | 546.14 | 543.84 | 541.95 |
Working Capital | 1,045 | 1,302 | 1,458 | 1,778 | 2,120 |
Book Value Per Share | 2.88 | 3.48 | 3.75 | 4.32 | 4.60 |
Tangible Book Value | 1,192 | 1,487 | 1,656 | 2,014 | 2,333 |
Tangible Book Value Per Share | 2.18 | 2.72 | 3.03 | 3.70 | 4.31 |
Machinery | - | 279.81 | 264.6 | 208.55 | 186.33 |
Construction In Progress | - | 20.76 | 32.38 | 61.42 | 18.33 |
Leasehold Improvements | - | 7.57 | 7.46 | 7.38 | 7.12 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.